Extended Data Table 1:
Patient collective.
| patient | sex | age range | Origin | Diagnosis | LP indication | MS Treatment | CSF cells/ul | OCB | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MS9 | female | 41–45 | Stanford | RRMS | diagnostic | none | 12 | + |
| 2 | MS12 | female | 16–20 | Heidelberg | CIS | diagnostic | none | 11 | + |
| 3 | MS20 | male | 21–25 | Heidelberg | CIS | diagnostic | none | 10 | + |
| 4 | MS21 | female | 36–40 | Heidelberg | RRMS | diagnostic | Fingolimod (paused for 4 weeks) | 15 | + |
| 5 | MS28 | female | 26–30 | Heidelberg | CIS | diagnostic | none | 17 | + |
| 6 | MS30 | female | 21–25 | Heidelberg | RRMS | diagnostic | none | 48 | + |
| 7 | MS31 | female | 21–25 | Heidelberg | CIS | diagnostic | none | 10 | + |
| 8 | MS37 | female | 16–20 | Heidelberg | CIS | diagnostic | none | 57 | + |
| 9 | MS39 | female | 26–30 | Stanford | RRMS | diagnostic | none | 18 | + |
| 10 | C3 | male | 60–65 | Heidelberg | neuroborreliosis | diagnostic | none | 825 | + |
| 11 | C5 | female | 45–50 | Heidelberg | neuro-Behçet’s | diagnostic | none | 56 | + |
| 12 | C6 | male | 75–80 | Heidelberg | viral encephalitis | diagnostic | none | 48 | + |